witching from EPA + DHA (omega-3-acid ethyl esters) to high-purity EPA (icosapent ethyl) in a statin-treated patient with persistent dyslipidemia and high cardiovascular risk: a case study Submitted by amarin on Fri, 10/04/2019 - 19:26 Home Read more about witching from EPA + DHA (omega-3-acid ethyl esters) to high-purity EPA (icosapent ethyl) in a statin-treated patient with persistent dyslipidemia and high cardiovascular risk: a case study
Lipid effects of switching from prescription EPA+DHA (omega-3-acid ethyl esters) to prescription EPA only (icosapent ethyl) in dyslipidemic patients Submitted by amarin on Fri, 10/04/2019 - 19:25 Home Read more about Lipid effects of switching from prescription EPA+DHA (omega-3-acid ethyl esters) to prescription EPA only (icosapent ethyl) in dyslipidemic patients
Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes. Submitted by amarin on Fri, 10/04/2019 - 19:23 Home Read more about Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes.
Triglycerides, atherosclerosis, and cardiovascular outcome studies: focus on omega-3 fatty acids Submitted by amarin on Fri, 10/04/2019 - 19:21 Home Read more about Triglycerides, atherosclerosis, and cardiovascular outcome studies: focus on omega-3 fatty acids
Omega-3 fatty acid fish oil dietary supplements contain saturated fats and oxidized lipids that may interfere with their intended biological benefits Submitted by amarin on Fri, 10/04/2019 - 19:19 Home Read more about Omega-3 fatty acid fish oil dietary supplements contain saturated fats and oxidized lipids that may interfere with their intended biological benefits
Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA) Submitted by amarin on Fri, 10/04/2019 - 19:16 Home Read more about Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)
Potential benefits of eicosapentaenoic acid on atherosclerotic plaques Submitted by amarin on Fri, 10/04/2019 - 18:50 Home Read more about Potential benefits of eicosapentaenoic acid on atherosclerotic plaques
Eicosapentaenoic acid as a potential therapeutic approach to reduce cardiovascular risk in patients with end-stage renal disease on hemodialysis: a review Submitted by amarin on Fri, 10/04/2019 - 18:43 Home Read more about Eicosapentaenoic acid as a potential therapeutic approach to reduce cardiovascular risk in patients with end-stage renal disease on hemodialysis: a review
Can pleiotropic effects of eicosapentaenoic acid (EPA) impact residual cardiovascular risk Submitted by amarin on Fri, 10/04/2019 - 18:41 Home Read more about Can pleiotropic effects of eicosapentaenoic acid (EPA) impact residual cardiovascular risk
Cardiovascular disease and omega-3s: Prescription products and fish oil dietary supplements are not the same Submitted by amarin on Fri, 10/04/2019 - 18:36 Home Read more about Cardiovascular disease and omega-3s: Prescription products and fish oil dietary supplements are not the same
